The stock surged following the European commercial launch of Revvity's GSP T1D 3plex kit for early Type 1 Diabetes screening.
read the report →← every name covered
S&P 500
RVTY
Revvity, Inc.
latest move
+6.03%
2026-09-24
5 sessions · 2026-09-15 → 2026-09-24 · avg 13.91% · largest 21.32%
Revvity, Inc. is a global health science solutions provider. It provides technologies, software, and services across its Diagnostics and Life Sciences segments.
Price history
stitched from the price window carried by each report
Every session it moved
newest first2026-09-24Bullish
+6.03%24 hours change2026-09-18Bullish
+15.40%weekly changeThe stock surged due to strong conference updates, strategic GLP-1 M&A, and price target hikes from Wall Street analysts.
read the report →2026-09-17Bullish
+21.32%weekly changeRevvity surged due to GLP-1 M&A, positive conference updates on AI demand, improved margin targets, and analyst upgrades.
read the report →2026-09-16Bullish
+17.67%weekly changeThe stock surged following a GLP-1 acquisition, upbeat conference commentary with raised guidance, and analyst price target hikes.
read the report →2026-09-15Bullish
+9.11%24 hours changeThe stock surged following healthcare conference presentations, the acquisition of Human Cell Design, and analyst price target upgrades.
read the report →